Leishmania parasites and their ploys to disrupt macrophage activation

Current Opinion in Hematology

Volumn 7, Issue 1, 2000, Pages 26-31

  Kane, Margaret Mentink ^a   Mosser, David M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PHOSPHATASE; PROTEIN KINASE C;

CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HOST PARASITE INTERACTION; LEISHMANIA; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROMASTIGOTE; REVIEW;

ANIMALS; HUMANS; LEISHMANIA; LEISHMANIASIS; LIGANDS; MACROPHAGE ACTIVATION; MACROPHAGES; RECEPTORS, CELL SURFACE;

EID: 0033987177     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200001000-00006     Document Type: Review

References (48)

1. 1 Wilson ME, Innes DJ, Sousa AD, Pearson RD: Early histopathology of experimental infection with L. donovani in hamsters. J Parasitol 1987, 73:55-63.
2. 2 Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, et al.: Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 1998, 188:1941-1953.
3. 3 Berman JD: Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997, 24:684-703.
4. 4 Reiner SL, Locksley RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 1995, 13:151-177.
5. 5 Mosser DM, Edelson PJ: The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of leishmania promastigotes. J Immunol 1985, 135:2785-2789.
6. 6 Mosser DM, Springer TA, Diamond MS: Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18). J CellBiol 1992, 116:511-520.
7. 7 Sutterwala FS, Rosenthal LA, Mosser DM: Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles. J Leukoc Biol 1996, 59:883-890.
8. 8 Brittingham A, Morrison CJ, McMaster WR, McGwire BS, Chang KP, Mosser DM: Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol 1995, 155:3102-3111.
9. 9 Mosser DM, Edelson PJ: The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature 1987, 327:329-331.
10. 10 Dominguez M, Torano A: Immune adherence-mediated opsonophagocytosis: the mechanism of Leishmania infection. J Exp Med 1999, 189:25-35.
11. 11 Mosser DM, Handman E: Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes. J Leukoc Biol 1992, 52:369-376.
12. 12 Handman E, Goding JW: The Leishmania receptor for macrophages is a lipid-containing glycoconjugate. EMBO J 1985, 4:329-336.
13. 13 Blackwell JM, Ezekowitz RAB, Roberts MB, Channon JY, Sim RB, Gordon S: Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med 1985, 162:324-331.
14. 14 Rizvi FS, Ouaissi MA, Marty B, Santoro F, Capron A: The major surface protein of Leishmania promastigotes is a fibronectin-like molecule. Eur J Immunol 1988, 18:473-476.
15. 15 Brittingham A, Chen G, McGwire BS, Chang K-P, Mosser DM: Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infect Immun 1999, 67:4477-4484. This work demonstrates that the efficient phagocytosis of Leishmania promastigotes may require the cooperation of multiple macrophage receptor classes.
16. 16 Gorak PM, Engwerda CR, Kaye PM: Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol 1998, 28:687-695. This study identifies the dendritic cell to be an important early source of interleukin-12 in mice infected with a visceralizing strain of Leishmania.
17. 17 Murray HW: Cell mediated immune response in experimental visceral leishmaniasis: II: oxygen dependent killing of intracellular Leishmania donovani amastigotes. J Immunol 1982, 129:351-357.
18. 18 Murray HW, Cartelli DM: Killing of intracellular Leishmania donovani by human mononuclear phagocytes: evidence for oxygen-dependent and -independent leishmanicidal activity. J Clin Invest 1983, 72:32-44.
19. 19 Pearson RD, Harcus JL, Roberts D, Donowitz GR: Differential survival of Leishmania donovani amastigotes in human monocytes. J Immunol 1983, 131:1994-1999.
20. 20 Green SJ, Meltzer MS, Hibbs JB, Jr, Nacy CA: Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 1990, 144:278-283.
21. 21 Wei X-q, Charles IG, Smith A, Ure J, Feng G-j, Huang F-p, et al.: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375:408-411.
22. 22 Murray HW, Nathan CF: Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 1999, 189:741-746. This paper compares the relative importance of reactive nitrogen and oxygen intermediates in host defense to Leishmania.
23. 23 MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 1997, 15:323-350.
24. 24 Nozaki Y, Hasegawa Y, Ichiyama S, Nakashima I, Shimokata K: Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun 1997, 65:3644-3647.
25. 25 Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Becherel P, Debre P, et al.: The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci U S A 1995, 92:7804-7808.
26. 26 Descoteaux A, Turco SJ, Sacks DL, Matlashewski G: Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol 1991, 146:2747-2753.
27. 27 Olivier M, Baimbridge KG, Reiner NE: Stimulus-response coupling in monocytes infected with Leishmania: attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. J Immunol 1992, 148:1188-1196.
28. 28 Nandan D, Reiner NE: Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect Immun 1995, 63:4495-4500.
29. 29 Nandan D, Lo R, Reiner NE: Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-fos and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun 1999, 67:4055-4063. This paper represents a continuation of the elegant studies by this group to identify alterations in macrophage signaling following Leishmania phagocytosis.
30. 30 Olivier M, Romero-Gallo B-J, Matte C, Blanchette J, Posner BI, Tremblay MJ, Faure R: Modulation of interferon - induced macrophage activation by phosphotyrosine phosphatases inhibition. J Biol Chem 1998, 273:13944-13949.
31. 31 Olivier M, Brownsey RW, Reiner NE: Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc Natl Acad Sci U S A 1992, 89:7481-7485.
32. 32 McNeely TB, Turco SJ: Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan. Biochem Biophys Res Commun 1987, 148:653-657.
33. 33 Descoteaux A, Matlashewski G, Turco SJ: Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J Immunol 1992, 149:3008-3015.
34. 34 Giorgione JR, Turco SJ, Epand RM: Transbylayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. Proc Natl Acad Sci U S A 1996, 93:11634-11639.
35. 35 Corradin S, Mauel J, Ransijn A, Sturzinger C, Vergeres G: Down-regulation of MARCKs-related protein (MRP) in macrophages infected with Leishmania. J Biol Chem 1999, 274:16782-16787.
36. 36 Bogdan C, Paik J, Vodovotz Y, Nathan C: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992, 267:23301-23308.
37. 37 Vouldoukis I, Becherel PA, Riveros-Moreno V, Arock M, da Suva O, Debre P, et al.: Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 1997, 27:860-865.
38. 38 Li J, Hunter CA, Farrell JP: Anti-TGf-B treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J Immunol 1999, 162:974-979.
39. 39 Barral-Netto M, Barral A, Brownell CE, Skieky YA, Ellingsworth LR, Twardzik DR, Reed SG: Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 1992, 257:545-548.
40. 40 Groux H, Cottrez F, Rouleau M, Mauze S, Antonenko S, Hurst S, et al.: A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol 1999, 162:1723-1729. This study illustrates the power of interleukin-10 in vivo. The overexpression of interleukin-10 can inhibit macrophage activation and the subsequent killing of intracellular parasites, even in immunocompetent mice.
41. 41 Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, Sacks DL: Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996, 183:515-526.
42. 42 Weinheber N, Wolfram M, Harbecke D, Aebischer T: Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur J Immunol 1998, 28:2467-2477.
43. 43 Piedrafita D, Proukfoot L, Nikolaev AV, Xu D, Sands W, Feng G-J, et al.: Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur J Immunol 1999, 29:235-244.
44. 44 Belkaid Y, Butcher B, Sacks DL: Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur J Immunol 1998, 28:1389-1400. This work confirms the previous in vitro studies by this group and extends them by demonstrating that macrophages infected with Leishmania in tissue fail to produce interleukin-12.
45. 45 Sutterwala FS, Noel GJ, Clynes R, Mosser DM: Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 1997, 185:1977-1985.
46. 46 Marth T, Kelsall BL: Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 1998, 185:1987-1995. This paper demonstrates that ligation of macrophage complement receptors prevents interleukin-12 production.
47. 47 Peters C, Aebischer T, Stierhof YD, Fuchs M, Overath P: The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes. J Cell Sci 1995, 108:3715-3724.
48. 48 Sutterwala FS, Noel GJ, Salgame P, Mosser DM: Reversal of proinflammatory responses by ligating the macrophage Fcg receptor type I. J Exp Med 1998, 188:217-222.